🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Congenital Disorders of Glycosylation

Assessing the Safety and Tolerability of NMN in DHDDS-CDG NCT07572825Phase 11 site📍 New York Eva Morava-Kozicz · Tests: Nicotinamide Mononucleotide (NMN) Nucleosidase Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation NCT02089789n/a1 site📍 Bethesda National Human Genome Research Institute (NHGRI) Clinical and Basic Investigations Into Congenital Disorders of Glycosylation NCT04199000n/a12 sites📍 San Diego📍 Aurora📍 Jacksonville Icahn School of Medicine at Mount Sinai Congenital Muscle Disease Study of Patient and Family Reported Medical Information NCT01403402n/a1 site📍 Lakewood Cure CMD
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy